Yüklüyor......
Proteasome Inhibition and Combination Therapy for Non-Hodgkin's Lymphoma: From Bench to Bedside
Although patients with B-cell non-Hodgkin's lymphoma (NHL) usually respond to initial conventional chemotherapy, they often relapse and mortality has continued to increase over the last three decades in spite of salvage therapy or high dose therapy and stem cell transplantation. Outcomes vary b...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AlphaMed Press
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3360909/ https://ncbi.nlm.nih.gov/pubmed/22566373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0341 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|